Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH

Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH

Mesenchymal stromal cell (MSC) transplantation ameliorated hepatic lipid load; tissue inflammation; and fibrosis in rodent animal models of non-alcoholic steatohepatitis (NASH) by as yet largely unknown mechanism(s). In a mouse model of NASH; we transplanted bone marrow-derived MSCs into the livers;...

Full description

Bibliographic Details
Main Authors:	Mei-Ju Hsu, Isabel Karkossa, Ingo Schäfer, Madlen Christ, Hagen Kühne, Kristin Schubert, Ulrike E. Rolle-Kampczyk, Stefan Kalkhof, Sandra Nickel, Peter Seibel, Martin von Bergen, Bruno Christ
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Biomedicines
Subjects:	non-alcoholic steatohepatitis (NASH) tunneling nanotubes (TNTs) primary hepatocytes organelle transfer mesenchymal stromal cells
Online Access:	https://www.mdpi.com/2227-9059/8/9/350

Similar Items

Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
by: Laurianne Bonnet, et al.
Published: (2022-08-01)

Human Mesenchymal Stromal Cells Resolve Lipid Load in High Fat Diet-Induced Non-Alcoholic Steatohepatitis in Mice by Mitochondria Donation
by: Sandra Nickel, et al.
Published: (2022-06-01)

Hepatocytes: A key role in liver inflammation
by: Jin Gong, et al.
Published: (2023-01-01)

Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers
by: Xiaobo Wang, et al.
Published: (2023-12-01)

Characterization of diseased primary human hepatocytes in an all-human cell-based triculture system
by: Justin J. Odanga, et al.
Published: (2024-03-01)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
by: Miriam Longo, et al.
Published: (2021-04-01)

Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study
by: Reda Albadawy, et al.
Published: (2021-09-01)

The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features
by: Akira Sasaki, et al.
Published: (2022-02-01)

Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes
by: Miori Tanaka, et al.
Published: (2020-05-01)

Circulatory <i>Endothelin 1-</i>Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
by: Reda Albadawy, et al.
Published: (2021-11-01)

Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) – A single arm clinical trial.
by: Shruti Tarapure, et al.
Published: (2021-01-01)

Role of Tunneling Nanotubes in the Nervous System
by: Olga Tarasiuk, et al.
Published: (2022-10-01)

Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
by: Dana Balitzer, et al.
Published: (2022-08-01)

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro
by: Teng Zhang, et al.
Published: (2024-02-01)

Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH
by: Eduardo E. Vargas-Pozada, et al.
Published: (2023-01-01)

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
by: Hegazy M, et al.
Published: (2020-02-01)

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
by: Martina Colognesi, et al.
Published: (2020-07-01)

Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
by: Mary Patricia Moore, et al.
Published: (2023-05-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
by: Utibe-Abasi S. Udoh, et al.
Published: (2022-07-01)

Highly Specialized Mechanisms for Mitochondrial Transport in Neurons: From Intracellular Mobility to Intercellular Transfer of Mitochondria
by: Marta Zaninello, et al.
Published: (2023-06-01)

Direct Cell-Cell Communication via Membrane Pores, Gap Junction Channels, and Tunneling Nanotubes: Medical Relevance of Mitochondrial Exchange
by: Eliseo Eugenin, et al.
Published: (2022-05-01)

MSC−sEV Treatment Polarizes Pro−Fibrotic M2 Macrophages without Exacerbating Liver Fibrosis in NASH
by: Bin Zhang, et al.
Published: (2023-04-01)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
by: Xiaoyan Qi, et al.
Published: (2022-11-01)

Labeled breath tests in patients with NASH: Octanoate oxidation relates best to measures of glucose metabolism
by: Justine M. Mucinski, et al.
Published: (2023-04-01)

Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
by: Gretchen Wolff, et al.
Published: (2022-06-01)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
by: Jin Ha Lee, et al.
Published: (2020-10-01)

Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress
by: Christiane Rennert, et al.
Published: (2020-09-01)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
by: Ana Sandoval-Rodriguez, et al.
Published: (2022-04-01)

Pathohistological characteristics of steatohepatitis on needle biopsy sample from 100 patients
by: Milićević Anđela, et al.
Published: (2019-01-01)

Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis
by: Ćulafić Milica, et al.
Published: (2020-01-01)

Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH
by: Archana Tewari, et al.
Published: (2023-07-01)

Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH[S]
by: George N. Ioannou, et al.
Published: (2017-06-01)

Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
by: Qiuhong Liu, et al.
Published: (2022-12-01)

Phenotype instability of hepatocyte-like cells produced by direct reprogramming of mesenchymal stromal cells
by: Iasmim Diniz Orge, et al.
Published: (2020-04-01)

Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor
by: Sharad K. Mittal, et al.
Published: (2019-10-01)

Corrigendum: Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
by: Qiuhong Liu, et al.
Published: (2023-01-01)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH
by: Meenakshi Vachher, et al.
Published: (2022-10-01)

The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
by: Wei Du, et al.
Published: (2022-06-01)

Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update
by: Sorina Cezara Coste, et al.
Published: (2019-05-01)